Professor, the University of Otago, Co-director, Genomics Aotearoa
Operating Partner, Bridgewest Group
Ian Wisenberg has been an integral leader charting innovation and growth across several Bridgewest Group companies since 2010. Ian’s philosophy “never do tomorrow what you can do today,” fuels his entrepreneurial successes. As Operating Partner, Ian focused on the expansion of the Life Sciences portfolio for Bridgewest Group in Australasia. He was most recently Founder and CEO for BioCina, where he led a highly accomplished team, recognized for its strong history as a multi-product biologics contract development and manufacturing organization (CDMO).
Prior to taking the helm at BioCina, Ian was founder and Chief Business Officer of BioArdis, a preclinical biopharmaceutical development company of the Bridgewest Group. He transitioned to this new role from Chief Financial Officer at BioDuro after the Bridgewest Group sale to Advent International in 2019. This was one a several transactions that Ian was intimately involved in over the past 20 years.
Ian also heads up a very successful consulting practice, BioGlobal Consulting Group with an extensive client list of biotech and pharma companies in the USA and internationally. His career spans over three decades in international business with an emphasis in finance, capital formation and business development. Ian is from Cape Town, South Africa, and attended the University of Cape Town.